6515 - BIOMERIEUX REAGENTS AND BLOOD CULTURE BOTTLES
ID: N6817124Q0139Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE NAVYNAVSUP FLC SIGONELLA NAPLES OFFICEFPO, AE, 09622-0050, USA

NAICS

Surgical and Medical Instrument Manufacturing (339112)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)
Timeline
    Description

    The Department of Defense, specifically the U.S. Navy, is seeking suppliers for laboratory reagents and blood culture bottles necessary for blood testing at the U.S. Navy Hospital in Naples, Italy. The procurement aims to acquire consumable supplies compatible with the Government-owned VITEK@2 Compact and BacT/ALERT@ 3D equipment utilized by the laboratory department. These supplies are critical for ensuring accurate and timely blood testing, which is essential for patient care and medical diagnostics. Interested vendors can reach out to Luca Buonocunto at the provided email or telephone number for further details regarding the solicitation process.

    Point(s) of Contact
    luca.buonocunto.ln@us.navy.mil
    luca.buonocunto.ln@us.navy.mil
    Files
    No associated files provided.
    Lifecycle
    Similar Opportunities
    Medical Sysmex Reagents and Microbiological Media Plates
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) Troop Support Pacific is conducting market research to identify local sources for the procurement and delivery of medical laboratory reagents and microbiological media plates in support of the United States Naval Hospital (USNH) located in Okinawa, Japan. This sources sought announcement aims to gather information on potential suppliers capable of fulfilling a requirement for Class VIII medical supplies, which are critical for laboratory diagnostics and healthcare operations. The anticipated contract will be a Firm-Fixed Price Indefinite Delivery, Indefinite Quantity type, with a base period of 12 months and one option period, estimated under $250,000, inclusive of shipping and delivery. Interested parties must submit their responses by 12:00 pm JST on October 13, 2024, to the designated contacts, Mamiko Jackson and Arlene Renner, via email.
    Intent to sole source Biomerieux Vitek2 Preventative maintenance and Consumables
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract to Biomerieux Japan Ltd. for the supply of specific VITEK 2 test cards and annual preventive maintenance services for the U.S. Naval Hospital Yokosuka and Branch Health Clinic Iwakuni in Japan. The procurement includes a delivery schedule spanning fiscal years 2025 to 2027, detailing quantities for three types of test cards essential for laboratory analyses, along with maintenance for two Vitek 2 Compact Analyzers. This contract is critical for ensuring effective healthcare delivery to U.S. Forces Japan personnel, and interested vendors may submit technical capability statements by 07:00 a.m. Pacific Time on 23 September 2024, to Raphael Badagbor at raphael.k.badagbor.civ@health.mil, as no competitive proposals will be solicited.
    Pharmaceutical Preparation Manufacturing
    Active
    Dept Of Defense
    Sources Sought DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is seeking local sources capable and interested in fulfilling a requirement for the procurement and delivery of CLASS VIII, Medical Laboratory Reagents, in support of United States Naval Hospital (USNH), located in Okinawa, Japan. The procurement is for ULTRA TECHNE KOW 18.5GBq Injection Generator, with an estimated quantity of 26 units per year. The delivery location will be the United States Naval Hospital (USNH) Okinawa Nuclear Medicine Department, Camp Foster, Okinawa, Japan. Interested parties should provide company information, capability to provide the items, and item lead times. Responses must be submitted by Thursday, November 09, 2023, via email to jasielle.castro@dla.mil and mamiko.jackson@dla.mil.
    6550--VISN Multiplex PCR Testing Reagents/Consumables Intent to sole source
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Great Lakes Acquisition Center, intends to negotiate a sole source contract with BioMerieux, Inc. for the provision of proprietary reagents and consumables necessary for PCR testing on government-owned devices across facilities in Wisconsin, Illinois, and Michigan. This procurement is essential to ensure that the VA can maintain high-quality healthcare services, as only BioMerieux is deemed capable of meeting the specialized requirements for these supplies. The contract will be established as a Blanket Purchase Agreement (BPA) under an existing contract, categorized as firm fixed price, and is being conducted in accordance with FAR 8.405-6. Interested firms must submit their qualifications and relevant customer references to the Contracting Officer, Teresa Beers, at teresa.beers@va.gov within seven calendar days from the publication date of this notice, as no competitive proposals will be solicited.
    Microbiology Supplies and Reagents at U.S. Naval Hospital Guam
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking qualified small businesses to provide microbiology supplies and reagents for the U.S. Naval Hospital in Guam. The procurement includes essential quality controls and reagents necessary for laboratory testing operations, with a delivery period from October 1, 2024, to September 30, 2025, and options for four additional years. This acquisition is critical for maintaining public health and ensuring reliable access to diagnostic tools within the military healthcare system. Interested contractors must submit their quotes electronically by 9:00 AM PDT on September 19, 2024, and can direct inquiries to Nicole Ventinilla at nicole.e.ventinilla.civ@health.mil.
    Luminex 200
    Active
    Dept Of Defense
    The Department of Defense, through the Naval Submarine Medical Research Laboratory (NSMRL), is seeking proposals for the procurement of a Luminex 200 Instrument System, which is essential for conducting antibody and RNA transcript analyses. This advanced analytical equipment will enable NSMRL to perform in-house biochemical analyses, facilitating the simultaneous detection of multiple proteins and gene expression, thereby improving the health and performance of Navy divers and submariners by addressing risks associated with oxygen toxicity and decompression stress. Interested contractors must submit their proposals by 8:00 AM on September 20, 2024, including detailed pricing and compliance with federal regulations, with a total funding amount of $63,000 for this sole source procurement from Thermofisher Scientific. For further inquiries, interested parties should contact Jessica Lindner at jessica.c.lindner2.civ@us.navy.mil.
    VWD, ABSORB CELL
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Navy through NAVSUP Weapon Systems Support Mechanicsburg, is soliciting proposals for the procurement of the VWD, Absorb Cell, a commercial product essential for measuring and testing electrical signals. The procurement requires adherence to specific design, material, and dimensional standards as outlined in the solicitation, with a focus on ensuring compliance with quality assurance and packaging requirements. This equipment plays a critical role in supporting military operations and maintaining the integrity of electrical testing processes. Interested vendors should direct inquiries to Lauren N. Valentine at 717-605-7191 or via email at LAUREN.N.VALENTINE2.CIV@US.NAVY.MIL, with proposals expected to comply with the detailed specifications and conditions set forth in the solicitation documents.
    USNA Chemistry Dept Microbial Bioreactor
    Active
    Dept Of Defense
    The Department of Defense, through the Naval Supply Systems Command Fleet Logistics Center Norfolk, is seeking qualified vendors to provide a Microbial Bioreactor for the United States Naval Academy's Chemistry Department. The procurement aims to acquire equipment that meets specific technical requirements, including the ability to control autoclavable vessels, integrated touchscreen monitoring, and gas regulation capabilities, which are essential for research and training in biotechnology and related fields. This bioreactor will facilitate the preparation of large quantities of chemical samples, supporting various scientific disciplines while ensuring ease of operation and minimal maintenance. Interested parties must submit their quotes electronically by 3:00 PM EST on September 19, 2024, to Caitlin King at caitlin.d.king2.civ@us.navy.mil, as no paper copies will be available for this solicitation.
    Laboratory Diagnostic Services
    Active
    Dept Of Defense
    The Department of Defense, specifically the Massachusetts Army National Guard (MA ARNG), is seeking qualified vendors to provide laboratory diagnostic services for its personnel from September 30, 2024, to September 29, 2025. The contractor will be responsible for delivering comprehensive blood and urine laboratory services, including staffing, equipment, and adherence to strict quality control measures, ensuring timely collection, transportation, and testing of samples. These services are crucial for maintaining the health readiness of soldiers, as they must meet specific medical requirements for duty. Interested small businesses must submit their quotes via email by the specified deadline, and further inquiries can be directed to Lacy Phongsaly at lacy.r.phongsaly.civ@army.mil or Lars Bernard at jeffrey.l.bernard6.civ@army.mil. The solicitation number for this opportunity is W912SV-24-Q-0024.
    Kidney Reagents for Luminex 3D Analyzer
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract for Kidney Reagents for the Luminex 3D Analyzer, specifically for the Kidney Transplant Clinic at The Walter Reed National Military Medical Center in Bethesda, Maryland. The procurement aims to secure molecular and serological reagents from One Lambda Inc. that are essential for transplant testing, ensuring compatibility and reducing the risk of organ rejection between donors and recipients. These reagents are critical as they have been validated by the American Society of Histocompatibility and Immunogenetics (ASHI) and are necessary for maintaining the accreditation of the Immunology Lab. Interested parties may express their interest and provide a capability statement to Barbara Sonnier at barbara.n.sonnier.civ@health.mil by September 24, 2024, at 10:00 PM EST.